Stock SENS SENSEONICS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Senseonics Holdings, Inc.

Equities

SENS

US81727U1051

Market Closed - Nyse
Other stock markets
 21:00:00 03/05/2024 BST 		5-day change 1st Jan Change
0.5049 USD -2.55% Intraday chart for Senseonics Holdings, Inc. +21.46% -11.44%
04-30 Senseonics Holdings, Inc. Announces Eversense CGM System Receives iCGM Designation by the U.S. Food and Drug Administration CI
03-25 Senseonics Holdings, Inc. Announces Board Changes CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Senseonics Holdings, Inc. Announces Eversense CGM System Receives iCGM Designation by the U.S. Food and Drug Administration
Senseonics Holdings, Inc. Announces Board Changes
Senseonics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Senseonics Holdings, Inc. Provides Revenue Guidance for the First Half of 2024
Senseonics Q4 Revenue Guidance Tops Consensus
Senseonics Holdings, Inc. Provides Earnings Guidance for the Year 2023
Senseonics Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Senseonics Holdings, Inc. Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study
Insider Buy: Senseonics Holdings
Senseonics Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Senseonics Holdings, Inc. Reiterates Revenue Guidance for the Full Year 2023
Sensonics Holdings, Inc. Announces New Clinical Data Demonstrating the Safety and Accuracy of Eversense Through 365 Days Presented at the American Diabetes Association 83rd Scientific Sessions
Senseonics Says UnitedHealthcare to Cover Eversense E3 Continuous Glucose Monitoring System; Shares Rise
Senseonics Holdings, Inc. Elects Koichiro Sato as Directors
Senseonics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Senseonics Holdings, Inc. Reiterates Revenue Guidance for the Full Year 2023
Senseonics Holdings, Inc. Announces First Pediatric Study Participant Insertions in ENHANCE Clinical Trial
Senseonics Holdings, Inc. Provides Revenue Guidance for the Full Year 2023
Senseonics Holdings, Inc. Revises Revenue Guidance for Full Year 2022
Senseonics Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SENS Stock
  4. News Senseonics Holdings, Inc.
  5. Other languages